Precision in Uncertainty: Strategic Infectious Disease Intelligence Solutions Tailored to your Organisation

The difficulty in identifying and sourcing country-level data should never be underestimated. Despite the unprecedented level of public data sharing during the pandemic, COVID-19 data is becoming increasingly fragmented, with no standardized way for collecting and reporting epidemiology data, reflecting the wider infectious disease landscape. These datasets are often hidden within country-level organisations and only present in local languages.

Airfinity’s solution is the only place where country-level primary data can be directly accessed. Explore all available data as it is reported by each country, helping you understand the disease development as well as speak the data language of each country.

Having a true understanding of disease burden is essential to stay ahead of your competition, enter new markets, and accelerate innovation. We contextualise all data and intelligence to allow you to assess the commercial impact of scientific and disease developments.

Our team of domain-experts are on hand to quickly respond to questions and concerns from our clients and partners to help them track, analyse and predict the ongoing situation.

Request more information about Airfinity's Epidemiological Intelligence

We’ll need a few short details about you and your business.

Science360 Laptop Mock Image

Request more information about Airfinity's Epidemiological Intelligence

We’ll need a few short details about you and your business.

What our users say?

who

“The Airfinity report is a guide for world leaders to fix a more ambitious action plan.”

Gordon Brown, WHO Ambassador for Global Health Financing & former UK Prime Minister

hm government

“Airfinity has been instrumental in our country's COVID response.”

Head of UK Government
Vaccine Task Force

ifpma

In a dynamic environment, Airfinity enabled us to remain on track with daily developments to enable more accurate decision-making. Airfinity combines nimbleness of real time data and their group of scientists that can analyse, model and provide strategic analysis for critical decision making.”

Iskra Reic, Executive Vice-President
Astrazeneca

Oxford

“Probably the most expansive, accurate and helpful of the multiple data sets on an international scale”

Sir John Bell ,
University of Oxford